- €1.03bn
- €1.47bn
- €3.07bn
Brief: Uniphar Says Well Positioned To Deliver FY Organic Gross Profit Growth Across All Divisions
Brief: Uniphar FY adjusted pretax profit EUR 53.321 million
2023 Preliminary Results
Holding(s) in Company
Brief: Uniphar Says Co Sees 2024 Organic Gross Profit Growth For Uniphar Pharma Up Double Digit
Directorate Change
Full Year Trading Update and Notice of Results
Directorate Change
Holding(s) in Company
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Brief: Uniphar Remains Well Positioned To Achieve Continued Gross Profit Growth In Each Division
2023 Interim Results
Holding(s) in Company
Holding(s) in Company